Inovio Pharmaceuticals Inc (INO)

1.83 +0.04 (+2.23%) USD  |  NASDAQ  |  Dec 24, 16:00
More

Inovio Pharmaceuticals Research and Development Expense (Quarterly): 18.73M for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for INO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Novavax Inc 87.16M
Baxter International Inc 129.00M
Candel Therapeutics Inc 5.416M
AIM ImmunoTech Inc 1.437M
Protalix BioTherapeutics Inc 2.998M